EO2040 in Combination With Nivolumab, for Treatment of Patients With Minimal Residual Disease of Colorectal Cancer
Clinical trial NCT05350501 · TERMINATED
Trial details
- NCT number
- NCT05350501
- Sponsor
- Enterome
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2024-01-23
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.